Board

About us

The board consists of seven ordinary members and two alternates. Alternates attend all meetings and contribute to the board’s work in the same way as the ordinary members. As of November 1, 2023, the board consists of:

Board member, chair and LVS representative

Mette Bliddal

Associate Professor, PhD
OPEN, Odense University Hospital University of Southern Denmark

Board member, vice-chair, NorPEN representative

Kristine Højgaard Allin

Associate Professor, MD, PhD
Center for Molecular Prediction of
Inflammatory Bowel Disease – PREDICT,
Aalborg University, Copenhagen

Board member, social media manager

Cathrine Hjorth

Postdoc, MSc, PhD
Dept. of Clinical Epidemiology
Aarhus University & Aarhus University Hospital

Board member, DSF and LVS representative

Marie Lund

Staff Specialist, MD PhD
Dept. of Clinical Pharmacology
Bispebjerg & Frederiksberg Hospital

Board member, DSF representative

Tea Skaaby

Head of Department, MD, PhD, Med.Sc.D.
Real-World Evidence, Data Analytics and Clinical Outcome Assesment
LEO Pharma A/S

Board member, treasurer

Lotte Husemoen

Principal Epidemiologist, MSc, PhD
Real World Science
Novo Nordisk A/S

Board member, webmaster

Signe Sørup

Clinical Specialist, MSc, PhD
Dept. of Clinical Epidemiology
Aarhus University & Aarhus University Hospital

Alternate, webmaster

Nils Skajaa

Senior Epidemiologist, MSc, PhD
Real World Science
Novo Nordisk A/S

Alternate, secretary, DSF representative

Helene Kildegaard

PhD Student, MD
Clinical Pharmacology, Pharmacy, and Environmental Medicine
University Southern Denmark

Previous board members from 1995

November 2022

Following the general meeting in November 2022, the board consists of:
Mette Bliddal (chair and LVS representative), Associate professor, OPEN, Odense University Hospital & University of Southern Denmark
Lina Steinrud Mørch (vice chair, LVS representative and NorPEN executive committee member), Group Leader, Senior Researcher, Cancer Surveillance and Pharmacoepidemiology, Danish Cancer Society
Marie Lund (DSF representative), Staff Specialist, Dept. of Clinical Pharmacology
Bispebjerg & Frederiksberg Hospital
Lotte Husemoen (Treasurer), Principal Epidemiologist, Novo Nordisk
Tea Skaaby (Secretary), Head of section, LEO Pharma
Signe Sørup (webmaster), Clinical Specialist, Aarhus University Hospital
Cathrine Hjort (Social media and event manager), PostDoc, Aarhus University
Mikkel Højlund (Alternate, event manager), MD, PhD, Mental Health Services, Region of Southern Denmark &University of Southern Denmark
Kristine Højgaard Allin (Alternate, event manager), Associate Professor, Aalborg University, Copenhagen

November 2021

Following the general meeting in October 2021, the board consists of:
Mette Bliddal (chair), Associate professor,OPEN, Odense University Hospital & University of Southern Denmark
Lina Steinrud Mørch (vice chair), Group Leader, Senior Researcher, Cancer Surveillance and Pharmacoepidemiology, Danish Cancer Society
Marie Lund (DSF +LVS contact), Staff Specialist, Dept. of Clinical Pharmacology
Bispebjerg & Frederiksberg Hospital
Lotte Husemoen (Treasurer), Epidemiology Specialist, Novo Nordisk
Tea Skaaby (Secretary), Senior pharmacoepidemiologist, LEO Pharma
Signe Sørup (webmaster), Clinical Specialist, Aarhus University Hospital
Cathrine Hjort (twitter responsible), PhD Student, Aarhus University
Kasper Bonnesen (Alternate, event coordinator), PhD Student, Aarhus University
Mikkel Højlund (Alternate, event coordinator), PhD Student, Mental Health Services, Region of Southern Denmark &University of Southern Denmark

November 2020

Following the general meeting in October 2020, the board consists of:
Mette Bliddal (chair), lektor, Syddansk Universitet & Odense Universitetshospital
Lina Steinrud Mørch (vice chair), gruppeleder og seniorforsker, Kræftens bekæmpelse
Anne Broe (webmaster), post doc, Odense Universitetshospital
Marie Lund (DSF +LVS contact), H-læge,Herlev Hospital
Lotte Husemoen (Treasurer), Novo Nordisk
Tea Skaaby (Secretary), senior pharmacoepidemiolog, LEO Pharma
Signe Sørup (Alternate, webmaster ass), post doc, Aarhus Universitet
Cathrine Hjort (Alternate, twitter responsible), ph.d. studerende, Aarhus Universitet
Kasper Bonnesen (event coordinator), ph.d. studerende, Aarhus Universitet

November 2019

Following the general meeting in October 2019, the board consists of:
Mette Bliddal, lektor, Syddansk Universitet & Odense Universitetshospital
Lina Steinrud Mørch, gruppeleder og seniorforsker, Kræftens bekæmpelse
Anne Broe, post doc, Odense Universitetshospital
Kasper Kristensen, ph.d.-studerende, Syddansk Universitet
Klaus Kaae Andersen, Scientific Leader, AstraZeneca
Marie Lund, H-læge,Herlev Hospital
Deirdre Cronin Fenton, lektor, Aarhus Universitetshospital
Kristina Laugesen, ph.d.-studerende, Aarhus Universitetshospital
Lotte Husemoen, Novo Nordisk

November 2018

Following the general meeting in November 2018, the Board consists of:
Anton Pottegård (chair), lektor, Syddansk Universitet
Lina Steinrud Mørch (vicechair), gruppeleder og seniorforsker, Novo Nordisk
Anne Broe (treasurer, webmaster), postdoc, Odense Universitetshospital
Kasper Kristensen (eventmanager), ph.d.-studerende, Syddansk Universitet
Kasper Adelborg (LVS-contact), H-læge, Aarhus Universitetshospital
Klaus Kaae Andersen, chefstatistiker, Kræftens Bekæmpelse
Marie Lund, H-læge, Herlev Hospital
Deirdre Cronin Fenton (alternate), lektor, Aarhus Universitetshospital
Kristina Laugesen (secretary, alternate), ph.d.-studerende, Aarhus Universitetshospital

November 2017

Following the general meeting in November 2017, the Board consists of :
Anton Pottegård (chair), lektor, Syddansk Universitet
Lina Steinrud Mørch (vice chair), gruppeleder og seniorforsker, Novo Nordisk
Anne Broe, ph.d.-studerende, Odense Universitetshospital
Maja Hellfritzsch Poulsen, ph.d.-studerende, Syddansk Universitet
Kasper Adelborg, H-læge, Aarhus Universitetshospital
Thomas Bo Jensen, ph.d.-studerende, Bisbebjerg Hospital
Michael Busch-Sørensen, Institute of Applied Economics & Health Research (ApHER)
Deirdre Cronin Fenton (alternate), lektor, Aarhus Universitetshospital
Kristina Laugesen (alternate), ph.d.-studerende, Aarhus Universitetshospital

December 2016

Following the general meeting in December 2016, the Board consists of :
Anton Pottegård (chair)
Deirdre Cronin Fenton
Anders Rething Borglykke
Sigrun Alba Johannesdottir Schmidt
Morten Schmidt
Michael Busch-Sørensen
Daniel Pilsgaard Henriksen

October 2015

Following the general meeting in October 2015, the Board consists of :
Anton Pottegård
Christian Fynbo Christiansen
Anders Rething Borglykke
Sigrun Alba Johannesdottir Schmidt
Morten Schmidt
Michael Busch-Sørensen
Daniel Pilsgaard Henriksen

October 2014

Following the general meeting in October 2014, the Board consists of :
Anne-Marie Schjerning Olsen (chair)
Christian Fynbo Christiansen (vice chair)
Espen Jimenez Solem
Anton Pottegård
Morten Schmidt

September 2013

Following the general meeting in September 2013, the Board consists of :
Anne-Marie Schjerning Olsen
Helle Wallach Kildemoes
Christian Fynbo Christiansen
Espen Jimenez Solem
Anton Pottegård

September 2012

Following the general meeting in March 2012, the Board consists of :
Gunnar H. Gislason, overlæge, seniorforsker, ph.d. Kardiologisk afdeing P, Gentofte Hospital (chair)
Helle Wallach Kildemoes, post-doc, ph.d. Institut for Folkesundhedsvidenskab, Københavns Universitet (treasurer)
Helge Gydesen, Senior Epidemiology Scientist, PhD Novo Nordisk (secretary)
Christian Fynbo Christiansen, post-doc, Klinisk Epidemiologisk Afdeling, Aarhus Universitetshospital
Anne-Marie Schjerning Olsen, ph.d.-studerende, Kardiologisk afdeling, Gentofte Hospital

April 2010

Following the general meeting in April 2010, the Board consists of :
overlæge, seniorforsker, ph.d. Gunnar H. Gislason, Kardiologisk afdeling P, Gentofte Hospital (formand);
overlæge, ph.d. Mette Nørgaard, Klinisk Epidemiologisk Afdeling, Aarhus Universitetshospital (kasserer);
Associate Principal, cand.pharm. Henny Bang Jakobsen, Nycomed (sekretær);
post-doc, ph.d. Helle Wallach Kildemoes, Institut for Folkesundhedsvidenskab, Københavns Universitet;
akademisk medarbejder, ph.d. Maja Laursen, Lægemiddelstyrelsen.

June 2009

Bestyrelsen består efter generalforsamlingen i februar 2009 af
afdelingslæge, ph.d. Gunnar Gislason, Hjerteforeningen (formand);
overlæge, ph.d. Mette Nørgaard, Region Nordjylland (kasserer);
seniorforsker, ph.d. Morten Andersen, Forskningsenheden for Almen Praksis, Syddansk Universitet – Odense (sekretær);
lektor, ph.d. (pharm.) Birthe Søndergaard, Institut for Farmakologi og Farmakoterapi, Det Farmaceutiske Fakultet, Københavns Universitet;
klinisk projektleder Henny Bang Jakobsen, Nycomed.

February 2008

Bestyrelsen består efter generalforsamlingen i november 2007 af
professor, dr.med. Jesper Hallas, IST – Forskningsenheden for Klinisk Farmakologi, Syddansk Universitet – Odense (formand);
seniorforsker, ph.d. Morten Andersen, Forskningsenheden for Almen Praksis, Syddansk Universitet – Odense;
lektor Birthe Søndergaard, Institut for Farmakologi og Far- makoterapi, Det Farmaceutiske Fakultet, Kø- benhavns Universitet (kasserer);
forskningsassistent, ph.d. Pia Wogelius, Klinisk Epidemiologisk Afdeling, Ålborg Hospital
Betina Østergaard Eriksen, Head of International Drug Safety, Nycomed. Selskabets revisor er afdelingschef, cand.oecon.

July 2007

Bestyrelsen består efter generalforsamlingen i november 2006 af
professor, dr.med. Jesper Hallas, Forskningsenheden for Klinisk Farmakologi, Syddansk Universitet – Odense (formand);
seniorforsker, ph.d. Morten Andersen, Forskningsenheden for Almen Praksis, Syddansk Universitet – Odense;
lektor Birthe Søndergaard, Institut for Farmakologi og Farmakoterapi, Det Farmaceutiske Fakultet, Københavns Universitet;
forskningsassistent, ph.d. Pia Wogelius, Klinisk Epidemiologisk Afdeling, Ålborg Hospital
Medical Director Betina Østergaard Eriksen, Alpharma (kasserer).

December 2005

Bestyrelsen består efter generalforsamlingen i november 2005 af
seniorforsker, ph.d. Morten Andersen, Forskningsenheden for Almen Praksis, Syddansk Universitet – Odense (formand);
overlæge, ph.d. Bente Nørgård, Klinisk Epidemiologisk Afdeling, Århus Uni- versitetshospital;
adjunkt, ph.d. Merete W. Nielsen, Institut for Samfundsfarmaci, Danmarks Farmaceutiske Universitet;
forskningsassistent, ph.d. Pia Wogelius, Klinisk Epidemiologisk Afdeling, Ålborg Hospital
Medical Director Betina Østergaard-Eriksen, Alpharma.

November 2004

Bestyrelsen består efter generalforsamlingen i november 2004 af
overlæge, ph.d. Bente Nørgård, Klinisk Epidemiologisk Afdeling, Århus Universitetshospital (formand);
Director Central Pharmacovigilance, cand.med. Jens Peter Balling, Nycomed Pharma, Roskilde (kasserer);
praktiserende læge, ph.d. John Larsen, Almen Medicin, Syddansk Universitet – Odense (sekretær);
professor, overlæge, dr.med. Jesper Hallas, Syddansk Universitet –
Odense og OUH;
adjunkt, ph.d. Merete W. Nielsen, Institut for Samfundsfarmaci, Dan-marks Farmaceutiske Universitet.

March 2004

Bestyrelsen består efter generalforsamlingen i november 2003 af projektmedarbejder, ph.d. (pharm.) Pia Knudsen, Pharmakon (formand);
Director Central Pharmacovigilance, cand.med. Jens Peter Balling, Nycomed Pharma, Roskilde (kasserer);
praktiserende læge ph.d. John Larsen (sekretær);
overlæge, dr.med. Jesper Hallas, Medicinsk afd. C,Odense Universitetshospital
konst. overlæge, ph.d. Bente Nørgård, Klinisk Epidemiologisk Afdeling, Århus Kommunehospital.

May 2003

Bestyrelsen består efter generalforsamlingen i november 2002 af
overlæge, dr.med. Jesper Hallas, Medicinsk afd. C, Odense Universitetshospital (formand);
praktiserende læge, ph.d. John Larsen (sekretær);
Director Central Pharmacovigilance, cand.med. Jens Peter Balling, Nycomed Pharma, Roskilde (kasserer);
adjunkt, ph.d. (pharm.) Pia Knudsen, Danmarks Farmaceutiske Universitet, Institut for Samfundsfarmaci
læge, ph.d. Bente Nørgaard, Klinisk Epidemiologisk Afdeling, Århus Kommunehospital.

July 2002

Bestyrelsen består af
overlæge, dr.med. Jesper Hallas, Medicinsk afd. C, Odense Universitetshospital (formand);
praktiserende læge, ph.d. John Larsen (sekretær);
cand.pharm. Bente Overgaard Larsen, Fyns Amt, Afdelingen for forebyggelse og sundhed (kasserer);
adjunkt, cand.pharm. Pia Knudsen, Danmarks Farmaceutiske Højskole, Institut for Samfundsfarmaci
Director Central Pharmacovigilance, cand.med. Jens Peter Balling, Nycomed Pharma, Roskilde.

July 2002

November 2001

Bestyrelsen består af
lektor, cand. med., ph.d. Morten Andersen, Klinisk Farmakologi, Syddansk Universitet – Odense Universitet (formand);
1. reservelæge, ph.d., Jens-Ulrik Rosholm, geriatrisk afdeling G, Odense Universitetshospital (sekretær);
cand.pharm. Bente Overgaard Larsen, Fyns Amt, Afdelingen for forebyggelse og sundhed (kasserer),
cand. pharm., ph.d.-studerende Pia Knudsen, Danmarks Farmaceutiske Højskole, Institut for Samfundsfarmaci
overlæge, ph.d. Jens Tølbøll Mortensen, Arbejds- og miljømedicinsk afd., Skive Sygehus.

June 2001

October 2000

Bestyrelsen består af
lektor, cand.med., ph.d. Morten Andersen, Klinisk Farmakologi, Syddansk Universitet – Odense Universitet (formand);
1. reservelæge, ph.d., Jens-Ulrik Rosholm, Medicinsk afdeling, Fredericia Sygehus (sekretær);
cand.pharm. Bente Overgaard Larsen, Fyns Amt, Sundhedssekretariatet (kasserer)
overlæge, Ph.D. Jens Tølbøll Mortensen, Klinisk Epidemiologi, Ålborg Sygehus.

November 1999

Bestyrelsen består p.t. af
cand.pharm., ph.d. Anna Almarsd6ttir, Institut for Samfundsfarmaci, Danmarks Farmaceutiske Højskole (formand);
adjunkt, cand.med., ph.d. Morten Andersen, Klinisk Farmakologi, Syddansk Universitet – Odense Universitet (sekretær);
1. reservelæge, dr.med. Jesper Hallas, Medicinsk afd., Svendborg Sygehus;
cand.pharm. Bente Overgaard Larsen, Fyns Amt, Sundhedssekretariatet;
cand.med. Flemming Hald Steffensen, Center for Epidemiologisk Grundforskning, Århus Universitet.

April 1999

November 1998

Bestyrelsen består p.t. af
1. reservelæge, dr.med. Jesper Hallas, Medicinsk afd., Svendborg Sygehus (formand);
adjunkt, cand.med., ph.d. Morten Andersen, Afdeling for Klinisk Farmakologi, Odense Universitet (sekretær);
cand.pharm., ph.d. Anna Almarsd6ttir, Institut for Samfundsfarmaci, Danmarks Farmaceutiske Højskole;
cand.med. Flemming Hald Steffensen, Center for Epidemiologisk Grundforskning, Århus Universitet og cand.polit.
Finn Ziegler, Glaxo Wellcome.

March 1998

October 1997

Bestyrelsen består p.t. af
1. reservelæge, dr.med. Jesper Hallas, Gastroenterologisk afd. S, Odense Universitetshospital (formand); kandidatstipendiat,
cand.med. David Gaist, Afdeling for Klinisk Farmakologi, Odense Universitet (sekretær);
cand.pharm., ph.d. Anna Almarsd6ttir, Institut for Samfundsfarmaci, Danmarks Farmaceutiske Højskole;
cand.med. Flemming Hald Steffensen, Center for Epide- miologisk Grundforskning, Århus Universitet
cand.polit. Finn Ziegler, Glaxo Wellcome.

April 1997

November 1996

Bestyrelsen består p.t. af
1. reservelæge Jesper Hallas, Gastroenterologisk afd. S, Odense Universitetshospital (formand);
kandidatstipendiat David Gaist, Afdeling for Klinisk Farmakologi, Odense Universitet (sekretær);
Professor Ebba Holme Hansen, Institut for Samfundsfarmaci, Danmarks Farmaceutiske Højskole;
cand.pharm. Aase Nissen, Lægemiddelafdelingen, Sundhedsstyrelsen
cand.pharm. Charlotte Steen Olsson, Eli Lilly Danmark A/S.

May 1996

November 1995

March 1995